Stroke News

The FDA has identified a recall by Cordis Corporation of the Precise PRO Rx US Carotid System as class I due to defects that may cause serious adverse events, according to a press release.

Stroke burden varied by racial/ethnic groups, with higher adjusted prevalence and incidence among Black participants compared with white participants, according to findings from a cross-sectional cohort study of more than 220,000 patients.

Nearly one-third of patients with atrial fibrillation and/or venous thromboembolism treated with a direct oral anticoagulant, or DOAC, were also using aspirin without clear indications, researchers reported.

Race, ethnicity and health insurance status all appeared to impact receipt of treatment for ischemic stroke among patients in California, Florida and New York, according to a retrospective analysis of more than 1 million hospitalizations.

The U.S. Preventive Services Task Force announced there is insufficient evidence to make a recommendation on screening asymptomatic patients aged 50 years and older for atrial fibrillation.

Nearly 14% of active smokers who survived a stroke use e-cigarettes, and those users were more inclined than e-cigarette nonusers to try to quit smoking within the past year, according to a research letter published in JAMA Neurology.

Continuous monitoring with an insertable cardiac monitor (Reveal LINQ, Medtronic) vs. standard care in patients with recent ischemic stroke.

Mobile stroke units vs. standard EMS response in patients with acute stroke.

Direct transfer to angiography suite vs. CT suite in patients with acute stroke who are candidates for endovascular treatment.

Patients with STEMI and COVID-19 were less likely to undergo primary PCI and were more likely to experience adverse outcomes compared with those who presented with STEMI before the pandemic, researchers reported.